Previous 10 | Next 10 |
2024-01-23 15:00:40 ET More on GSK GSK plc (GSK) 42nd Annual JP Morgan Healthcare Conference (Transcript) AbbVie Vs. GSK: Dual Dominance In Pharma GSK - Greenshoots In The Horizon GSK sells off partial stake in Haleon for $1.2B GSK to sell 3.2% stake ...
2024-01-12 12:54:48 ET Summary Viatris is an American pharmaceutical company formed as a result of the merger of Mylan and Upjohn. Over the past two and a half months, Viatris' share price has risen by more than 38%. Viatris' dividend yield is 3.97%, which is attractive becaus...
2024-01-11 01:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-05 09:20:37 ET More on Journey Medical, Dr. Reddy's, etc. The Strategic Evolution Of Journey Medical In Dermatological Care Dr. Reddy's Laboratories: Q2 Earnings Reveals Strong Growth And Promising Advancements Journey Medical Corporation (DERM) Q3 2023 Earni...
2024-01-03 06:16:20 ET Dr. Reddy's Laboratories ( NYSE: RDY ) on Wednesday announced a deal to acquire a women's health and dietary supplements portfolio of brands from Amyris ( OTC:AMRSQ ) as part of the latter's Chapter 11 sales process. Terms of the deal were not disc...
Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's"), today announced that it has acquired MenoLabs ® business, a leading women’s health and dietary supplement branded portfolio fr...
2023-12-29 14:52:48 ET More on Dr. Reddy's Dr. Reddy's Laboratories: Q2 Earnings Reveals Strong Growth And Promising Advancements Dr Reddy's Laboratories Ltd (RDY) Q2 2024 Earnings Call Transcript Dr. Reddy's: Continued Q2 Earnings Growth, Supports Long-Term Investme...
2023-12-24 02:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-14 12:30:25 ET The Biden administration on Thursday named 48 Medicare Part B drugs that could be subject to inflation penalties for Q1 2024, including products from the likes of AbbVie ( NYSE: ABBV ), Amgen ( NASDAQ: AMGN ), and Pfizer ( NYSE: PFE ). Drug...
Company also secures ‘Gold Medal’ status from global sustainability ratings agency, EcoVadis In a first for Indian pharma, Dr. Reddy’s is featured in the Dow Jones Sustainability World Index for 2023 Company retains its place in the Dow Jones Sustainability ...
News, Short Squeeze, Breakout and More Instantly...
Dr. Reddy's Laboratories Ltd Company Name:
RDY Stock Symbol:
NYSE Market:
Dr. Reddy's Laboratories Ltd Website:
2024-07-04 03:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Portfolio to be acquired consists of global NRT brand Nicotinell and its local market-leading brand names Nicabate, Habitrol and Thrive in markets outside of the United States Acquisition seen as ideal anchor to continue to build the company’s global consumer healthcare OTC busines...
Aurigene Pharmaceutical Services Limited (“Aurigene”), a Dr. Reddy’s Laboratories Limited company, inaugurated its biologics facility spread across 70,000 sq.ft. in Genome Valley, a bio cluster, located in Hyderabad, India. The facility is designed to serve customers with pro...